Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
5.76
+0.16 (2.86%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Profound Medical Market Cap
Profound Medical has a market cap or net worth of $211.11 million as of September 25, 2026. Its market cap has increased by 30.80% in one year.
Market Cap
211.11M
Enterprise Value
180.08M
1-Year Change
30.80%
Ranking
Category
Stock Price
$5.76
ChartMarket Cap Chart
Since October 30, 2019, Profound Medical's market cap has increased from $113.60M to $211.11M, an increase of 85.84%. That is a compound annual growth rate of 9.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 210.40M | -11.45% |
| Dec 31, 2025 | 237.60M | 28.29% |
| Dec 31, 2024 | 185.20M | 2.09% |
| Dec 29, 2023 | 181.40M | -20.19% |
| Dec 30, 2022 | 227.30M | -2.53% |
| Dec 31, 2021 | 233.20M | -42.21% |
| Dec 31, 2020 | 403.50M | 210.86% |
| Dec 31, 2019 | 129.80M | 14.26% |
| Oct 30, 2019 | 113.60M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Treace Medical Concepts | 292.66M |
| Standard BioTools | 290.47M |
| Perspective Therapeutics | 287.66M |
| TriSalus Life Sciences | 267.23M |
| InfuSystem Holdings | 253.15M |
| Electromed | 233.25M |
| Neuronetics | 208.78M |
| RxSight | 193.82M |